Filing Details

Accession Number:
0001209191-18-034197
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-30 17:15:40
Reporting Period:
2018-05-30
Accepted Time:
2018-05-30 17:15:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1659323 Iterum Therapeutics Plc ITRM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365617 J Patrick Heron C/O Iterum Therapeutics Plc, Blk 2
Fl. 3, Harcourt Centre, Harcourt St.
Dublin L2 2
Yes No Yes No
1553071 Frazier Healthcare Vii, L.p. 601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
1575192 Frazier Healthcare Vii-A, L.p. 601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
1654631 Fhm Vii, L.l.c. 601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
1654632 Fhm Vii, L.p. 601 Union Street, Suite 3200
Seattle WA 98101
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2018-05-30 495,370 $0.00 495,370 No 4 C Indirect By Frazier Healthcare VII, L.P.
Ordinary Shares Acquisiton 2018-05-30 189,141 $0.00 684,511 No 4 C Indirect By Frazier Healthcare VII, L.P.
Ordinary Shares Acquisiton 2018-05-30 157,701 $0.00 842,212 No 4 C Indirect By Frazier Healthcare VII, L.P.
Ordinary Shares Acquisiton 2018-05-30 354,949 $13.00 1,197,161 No 4 P Indirect By Frazier Healthcare VII, L.P.
Ordinary Shares Acquisiton 2018-05-30 141,166 $0.00 141,166 No 4 C Indirect By Frazier Healthcare VII-A, L.P.
Ordinary Shares Acquisiton 2018-05-30 53,899 $0.00 195,065 No 4 C Indirect By Frazier Healthcare VII-A, L.P.
Ordinary Shares Acquisiton 2018-05-30 44,940 $0.00 240,005 No 4 C Indirect By Frazier Healthcare VII-A, L.P.
Ordinary Shares Acquisiton 2018-05-30 101,150 $13.00 341,155 No 4 P Indirect By Frazier Healthcare VII-A, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Frazier Healthcare VII, L.P.
No 4 C Indirect By Frazier Healthcare VII, L.P.
No 4 C Indirect By Frazier Healthcare VII, L.P.
No 4 P Indirect By Frazier Healthcare VII, L.P.
No 4 C Indirect By Frazier Healthcare VII-A, L.P.
No 4 C Indirect By Frazier Healthcare VII-A, L.P.
No 4 C Indirect By Frazier Healthcare VII-A, L.P.
No 4 P Indirect By Frazier Healthcare VII-A, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Series A Preferred Shares Disposition 2018-05-30 495,370 $0.00 495,370 $0.00
Ordinary Shares Series B-1 Preferred Shares Disposition 2018-05-30 189,141 $0.00 189,141 $0.00
Ordinary Shares Series B-2 Preferred Shares Disposition 2018-05-30 157,701 $0.00 157,701 $0.00
Ordinary Shares Series A Preferred Shares Disposition 2018-05-30 141,166 $0.00 141,166 $0.00
Ordinary Shares Series B-1 Preferred Shares Disposition 2018-05-30 53,899 $0.00 53,899 $0.00
Ordinary Shares Series B-2 Preferred Shares Disposition 2018-05-30 44,940 $0.00 44,940 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
  2. These shares are held directly by Frazier Healthcare VII, L.P. ("FH VII"). The sole general partner of FH VII is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VII. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VII, except to the extent of his or its pecuniary interest therein, if any.
  3. The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
  4. The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer.
  5. These shares are held directly by Frazier Healthcare VII-A, L.P. ("FH VIIA"). The sole general partner of FH VIIA is FHM VII, L.P. and the general partner of FHM VII, L.P. is FHM VII, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by FH VIIA. The Reporting Person is one of six members of FHM VII, L.L.C. The Reporting Person, FHM VII, L.P. and FHM VII, L.L.C. disclaims Section 16 beneficial ownership of the securities held by FH VIIA, except to the extent of his or its pecuniary interest therein, if any.
  6. Not applicable.